167 related articles for article (PubMed ID: 17623671)
21. Interferon regulatory factor 1 and a variant of heterogeneous nuclear ribonucleoprotein L coordinately silence the gene for adhesion protein CEACAM1.
Dery KJ; Silver C; Yang L; Shively JE
J Biol Chem; 2018 Jun; 293(24):9277-9291. PubMed ID: 29720400
[TBL] [Abstract][Full Text] [Related]
22. CEACAM1 long isoform has opposite effects on the growth of human mastocytosis and medullary thyroid carcinoma cells.
Ueshima C; Kataoka TR; Takei Y; Hirata M; Sugimoto A; Hirokawa M; Okayama Y; Blumberg RS; Haga H
Cancer Med; 2017 Apr; 6(4):845-856. PubMed ID: 28332308
[TBL] [Abstract][Full Text] [Related]
23. The cytoplasmic domain of CEACAM1-L controls its lateral localization and the organization of desmosomes in polarized epithelial cells.
Sundberg U; Beauchemin N; Obrink B
J Cell Sci; 2004 Mar; 117(Pt 7):1091-104. PubMed ID: 14970258
[TBL] [Abstract][Full Text] [Related]
24. Tumor and endothelial cell-derived microvesicles carry distinct CEACAMs and influence T-cell behavior.
Muturi HT; Dreesen JD; Nilewski E; Jastrow H; Giebel B; Ergun S; Singer BB
PLoS One; 2013; 8(9):e74654. PubMed ID: 24040308
[TBL] [Abstract][Full Text] [Related]
25. Role of CEACAM1 isoforms in an in vivo model of mammary morphogenesis: mutational analysis of the cytoplasmic domain of CEACAM1-4S reveals key residues involved in lumen formation.
Yokoyama S; Chen CJ; Nguyen T; Shively JE
Oncogene; 2007 Dec; 26(55):7637-46. PubMed ID: 17546042
[TBL] [Abstract][Full Text] [Related]
26. CEACAM1 long cytoplasmic domain isoform is associated with invasion and recurrence of hepatocellular carcinoma.
Kiriyama S; Yokoyama S; Ueno M; Hayami S; Ieda J; Yamamoto N; Yamaguchi S; Mitani Y; Nakamura Y; Tani M; Mishra L; Shively JE; Yamaue H
Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S505-14. PubMed ID: 24390710
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of carcinoembryonic antigen-related cell adhesion molecule 1 in gastrointestinal cancer and its clinical relevance.
Zhou M; Jin Z; Liu Y; He Y; Du Y; Yang C; Wang Y; Hu J; Cui L; Gao F; Cao M
Acta Biochim Biophys Sin (Shanghai); 2017 Aug; 49(8):737-743. PubMed ID: 28655144
[TBL] [Abstract][Full Text] [Related]
28. Two variable regions in carcinoembryonic antigen-related cell adhesion molecule1 N-terminal domains located in or next to monoclonal antibody and adhesion epitopes show evidence of recombination in rat but not in human.
Comegys MM; Lin SH; Rand D; Britt D; Flanagan D; Callanan H; Brilliant K; Hixson DC
J Biol Chem; 2004 Aug; 279(33):35063-78. PubMed ID: 15184366
[TBL] [Abstract][Full Text] [Related]
29. CEACAM1 is a potent regulator of B cell receptor complex-induced activation.
Greicius G; Severinson E; Beauchemin N; Obrink B; Singer BB
J Leukoc Biol; 2003 Jul; 74(1):126-34. PubMed ID: 12832451
[TBL] [Abstract][Full Text] [Related]
30. Species-specific evolution of immune receptor tyrosine based activation motif-containing CEACAM1-related immune receptors in the dog.
Kammerer R; Popp T; Härtle S; Singer BB; Zimmermann W
BMC Evol Biol; 2007 Oct; 7():196. PubMed ID: 17945019
[TBL] [Abstract][Full Text] [Related]
31. Tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 potentates the anchorage-independent growth of human hepatoma HepG2 cells.
Hokari M; Matsuda Y; Wakai T; Shirai Y; Sato M; Tsuchiya A; Takamura M; Yamagiwa S; Suzuki K; Ohkoshi S; Ichida T; Kawachi H; Aoyagi Y
Life Sci; 2007 Jul; 81(4):336-45. PubMed ID: 17612570
[TBL] [Abstract][Full Text] [Related]
32. The transmembrane domain of CEACAM1-4S is a determinant of anchorage independent growth and tumorigenicity.
Lawson EL; Mills DR; Brilliant KE; Hixson DC
PLoS One; 2012; 7(1):e29606. PubMed ID: 22235309
[TBL] [Abstract][Full Text] [Related]
33. cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function.
Izzi L; Turbide C; Houde C; Kunath T; Beauchemin N
Oncogene; 1999 Sep; 18(40):5563-72. PubMed ID: 10523833
[TBL] [Abstract][Full Text] [Related]
34. Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36.
Chean J; Chen CJ; Gugiu G; Wong P; Cha S; Li H; Nguyen T; Bhatticharya S; Shively JE
J Biol Chem; 2021 Nov; 297(5):101311. PubMed ID: 34666041
[TBL] [Abstract][Full Text] [Related]
35. The CEACAM1 N-terminal Ig domain mediates cis- and trans-binding and is essential for allosteric rearrangements of CEACAM1 microclusters.
Klaile E; Vorontsova O; Sigmundsson K; Müller MM; Singer BB; Ofverstedt LG; Svensson S; Skoglund U; Obrink B
J Cell Biol; 2009 Nov; 187(4):553-67. PubMed ID: 19948502
[TBL] [Abstract][Full Text] [Related]
36. Mutation analysis of the short cytoplasmic domain of the cell-cell adhesion molecule CEACAM1 identifies residues that orchestrate actin binding and lumen formation.
Chen CJ; Kirshner J; Sherman MA; Hu W; Nguyen T; Shively JE
J Biol Chem; 2007 Feb; 282(8):5749-60. PubMed ID: 17192268
[TBL] [Abstract][Full Text] [Related]
37. Binding of
Klaile E; Müller MM; Schäfer MR; Clauder AK; Feer S; Heyl KA; Stock M; Klassert TE; Zipfel PF; Singer BB; Slevogt H
mBio; 2017 Mar; 8(2):. PubMed ID: 28292985
[No Abstract] [Full Text] [Related]
38. Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1.
Stern N; Markel G; Arnon TI; Gruda R; Wong H; Gray-Owen SD; Mandelboim O
J Immunol; 2005 Jun; 174(11):6692-701. PubMed ID: 15905509
[TBL] [Abstract][Full Text] [Related]
39. Lymphatic reprogramming of microvascular endothelial cells by CEA-related cell adhesion molecule-1 via interaction with VEGFR-3 and Prox1.
Kilic N; Oliveira-Ferrer L; Neshat-Vahid S; Irmak S; Obst-Pernberg K; Wurmbach JH; Loges S; Kilic E; Weil J; Lauke H; Tilki D; Singer BB; Ergün S
Blood; 2007 Dec; 110(13):4223-33. PubMed ID: 17761831
[TBL] [Abstract][Full Text] [Related]
40. Identification of a novel protein, PDIP38, that interacts with the p50 subunit of DNA polymerase delta and proliferating cell nuclear antigen.
Liu L; Rodriguez-Belmonte EM; Mazloum N; Xie B; Lee MY
J Biol Chem; 2003 Mar; 278(12):10041-7. PubMed ID: 12522211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
